Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Idealab is a prominent technology incubator founded by Bill Gross in 1996, focused on creating and operating pioneering companies across various sectors, including life sciences and healthcare. The company operates as a startup studio, providing the necessary resources, mentorship, and capital to transform innovative ideas into market-leading businesses. Within the healthcare space, Idealab has incubated several ventures aimed at improving patient outcomes and operational efficiencies through advanced technology. Its portfolio includes a diverse range of companies that leverage artificial intelligence, data analytics, and novel therapeutic approaches. Idealab's unique model emphasizes rapid prototyping and market validation to ensure the scalability of its incubated startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bill Gross.